• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示缺氧诱导因子2α(HIF2α)在黑色素瘤进展和上皮-间质转化中的作用。

Unraveling the role of HIF2α in melanoma progression and epithelial-mesenchymal transition.

作者信息

Han Zhao, Gao Yanling, Li Zhifeng, Liu Zhao, Zhang Jianzhong, Jing Tingting, Xv Yanyan, Miao Guoying, Li Xiaojing, Chen Aijun

机构信息

Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Yuanjiagang Youyi Road No. 1, Yuzhong District, Chongqing, 400010, China.

Department of Dermatology, The Affiliated Hospital of Hebei Engineering University, Congtai Road No. 81, Congtai District, Handan, 056000, Hebei, China.

出版信息

Sci Rep. 2025 Jul 1;15(1):21446. doi: 10.1038/s41598-025-02384-2.

DOI:10.1038/s41598-025-02384-2
PMID:40595758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12218896/
Abstract

Melanoma is a highly heterogeneous and aggressive malignancy. Hypoxia within the tumor microenvironment is closely associated with tumor progression. However, the role of hypoxia-inducible factor 2α (HIF2α), a key transcription factor, in melanoma remains poorly understood. In this study, transcriptome analysis compared HIF2α expression between melanoma patient and control samples. Single-cell RNA sequencing categorized cells into high- and low-HIF2α expression groups. Ligand-receptor interactions (CellChat), enrichment analysis (GSEA/GSVA), immune regulatory network, and metabolic pathway analyses were performed. The correlation between HIF2α and genes involved in hypoxia, autophagy, and epithelial-mesenchymal transition (EMT) was explored, alongside its relationship with clinical stage. Experimentally, A375 cells were cultured under normoxic and hypoxic conditions, transfected with ShRNA-NC or ShRNA-HIF2α, and mRNA levels of HIF2α, E-cadherin, N-cadherin, and Vimentin were quantified using real-time PCR. Differential expression analysis showed significant upregulation of HIF2α in melanoma samples. Ligand-receptor interaction analysis emphasized its role in modulating the tumor microenvironment. Enrichment analyses (GSEA/GSVA) revealed HIF2α involvement in key oncogenic pathways. Correlation analysis linked HIF2α to genes related to hypoxia, autophagy, and EMT, and its expression was associated with advanced clinical stages. In vitro, hypoxia increased HIF-2α, N-cadherin, and Vimentin mRNA levels, while decreasing E-cadherin. HIF-2α knockdown reversed these effects, promoting E-cadherin and suppressing N-cadherin and Vimentin under hypoxia. This study underscores the critical role of HIF2α in melanoma progression, suggesting its involvement in regulating the tumor microenvironment and associated metabolic pathways. As a potential biomarker and therapeutic target, HIF2α offers new insights into the clinical management and treatment of melanoma.

摘要

黑色素瘤是一种高度异质性和侵袭性的恶性肿瘤。肿瘤微环境中的缺氧与肿瘤进展密切相关。然而,关键转录因子缺氧诱导因子2α(HIF2α)在黑色素瘤中的作用仍知之甚少。在本研究中,转录组分析比较了黑色素瘤患者样本与对照样本中HIF2α的表达。单细胞RNA测序将细胞分为高HIF2α表达组和低HIF2α表达组。进行了配体-受体相互作用(CellChat)、富集分析(GSEA/GSVA)、免疫调节网络和代谢途径分析。探讨了HIF2α与缺氧、自噬和上皮-间质转化(EMT)相关基因之间的相关性,以及它与临床分期的关系。在实验中,将A375细胞在常氧和缺氧条件下培养,用ShRNA-NC或ShRNA-HIF2α转染,并使用实时PCR定量HIF2α、E-钙黏蛋白、N-钙黏蛋白和波形蛋白的mRNA水平。差异表达分析显示黑色素瘤样本中HIF2α显著上调。配体-受体相互作用分析强调了其在调节肿瘤微环境中的作用。富集分析(GSEA/GSVA)揭示HIF2α参与关键致癌途径。相关性分析将HIF2α与缺氧、自噬和EMT相关基因联系起来,其表达与晚期临床分期相关。在体外,缺氧增加了HIF-2α、N-钙黏蛋白和波形蛋白的mRNA水平,同时降低了E-钙黏蛋白。HIF-2α敲低逆转了这些效应,在缺氧条件下促进E-钙黏蛋白表达并抑制N-钙黏蛋白和波形蛋白。本研究强调了HIF2α在黑色素瘤进展中的关键作用,表明其参与调节肿瘤微环境和相关代谢途径。作为一种潜在的生物标志物和治疗靶点,HIF2α为黑色素瘤的临床管理和治疗提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/f4c5410ba654/41598_2025_2384_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/62bb659ae4be/41598_2025_2384_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/e56662d6a319/41598_2025_2384_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/7ed52308c61d/41598_2025_2384_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/ff085b280658/41598_2025_2384_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/efd6d381c458/41598_2025_2384_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/390735d2ad58/41598_2025_2384_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/06c65dfabf90/41598_2025_2384_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/745f8f7ef797/41598_2025_2384_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/a82ee0925e0e/41598_2025_2384_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/77718a4d1d29/41598_2025_2384_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/0c3e2121ce06/41598_2025_2384_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/f4c5410ba654/41598_2025_2384_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/62bb659ae4be/41598_2025_2384_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/e56662d6a319/41598_2025_2384_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/7ed52308c61d/41598_2025_2384_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/ff085b280658/41598_2025_2384_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/efd6d381c458/41598_2025_2384_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/390735d2ad58/41598_2025_2384_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/06c65dfabf90/41598_2025_2384_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/745f8f7ef797/41598_2025_2384_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/a82ee0925e0e/41598_2025_2384_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/77718a4d1d29/41598_2025_2384_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/0c3e2121ce06/41598_2025_2384_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/308c/12218896/f4c5410ba654/41598_2025_2384_Fig12_HTML.jpg

相似文献

1
Unraveling the role of HIF2α in melanoma progression and epithelial-mesenchymal transition.揭示缺氧诱导因子2α(HIF2α)在黑色素瘤进展和上皮-间质转化中的作用。
Sci Rep. 2025 Jul 1;15(1):21446. doi: 10.1038/s41598-025-02384-2.
2
Identification and validation of a KRAS-macrophage-associated gene signature as prognostic biomarkers and potential therapeutic targets in melanoma.鉴定和验证一种与KRAS-巨噬细胞相关的基因特征作为黑色素瘤的预后生物标志物和潜在治疗靶点。
Front Immunol. 2025 Jun 18;16:1566432. doi: 10.3389/fimmu.2025.1566432. eCollection 2025.
3
Comprehensive analysis of anosmin-1 as a potential biomarker and its correlation with epithelial-mesenchymal transition in advanced gastric cancer.嗅觉缺失蛋白-1作为晚期胃癌潜在生物标志物的综合分析及其与上皮-间质转化的相关性
3 Biotech. 2025 Jul;15(7):222. doi: 10.1007/s13205-025-04361-y. Epub 2025 Jun 21.
4
BAIAP2 as a driver of tumor progression in urothelial bladder cancer.BAIAP2作为尿路上皮膀胱癌肿瘤进展的驱动因素。
BMC Cancer. 2025 Jul 1;25(1):1057. doi: 10.1186/s12885-025-14470-9.
5
The role of JPT1 in hepatocellular carcinoma: tumor progression, microtubule dynamics regulation, and potential mechanisms within the immune microenvironment.JPT1在肝细胞癌中的作用:肿瘤进展、微管动力学调节及免疫微环境中的潜在机制
Discov Oncol. 2025 Jul 3;16(1):1258. doi: 10.1007/s12672-025-03066-1.
6
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM.全面的泛癌分析揭示NTN1作为一种免疫浸润风险因素及其在皮肤黑色素瘤中的潜在预后价值。
Sci Rep. 2025 Jan 25;15(1):3223. doi: 10.1038/s41598-025-85444-x.
7
Pleiotrophin promote glioma proliferation and invasion by enhancing NF-κB/SLUG mediated epithelial-mesenchymal transition.多效生长因子通过增强NF-κB/SLUG介导的上皮-间质转化促进胶质瘤的增殖和侵袭。
Eur J Med Res. 2025 Jul 2;30(1):545. doi: 10.1186/s40001-025-02808-9.
8
Elevated Expression in Uveal Melanoma Predicts Poor Patient Prognosis.葡萄膜黑色素瘤中表达升高预示患者预后不良。
Cancer Genomics Proteomics. 2025 Jun 26;22(4):624-631. doi: 10.21873/cgp.20526.
9
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
10
[Mechanisms of HNE mediated NLRP3 promoting EMT in chronic rhinosinusitis with polyps].[HNE介导NLRP3促进鼻息肉慢性鼻窦炎中EMT的机制]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jul;39(7):624-631. doi: 10.13201/j.issn.2096-7993.2025.07.005.

本文引用的文献

1
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma.缺氧上调肝血管生成素-2转录以促进肝细胞癌进展。
World J Hepatol. 2024 Dec 27;16(12):1480-1492. doi: 10.4254/wjh.v16.i12.1480.
2
Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma.探索黑色素瘤对免疫检查点抑制剂和靶向治疗的耐药性。
Cancer Drug Resist. 2024 Oct 31;7:42. doi: 10.20517/cdr.2024.54. eCollection 2024.
3
Hypoxia-induced BNIP3 facilitates the progression and metastasis of uveal melanoma by driving metabolic reprogramming.
缺氧诱导的BNIP3通过驱动代谢重编程促进葡萄膜黑色素瘤的进展和转移。
Autophagy. 2025 Jan;21(1):191-209. doi: 10.1080/15548627.2024.2395142. Epub 2024 Sep 12.
4
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic Cancer.肿瘤微环境中HIF-2和HIF-3概述:缺氧癌症治疗的发展概念
Curr Mol Med. 2024 May 17. doi: 10.2174/0115665240303179240427071748.
5
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.肿瘤相关巨噬细胞作为当前和未来黑色素瘤治疗的关键贡献者和靶点。
Expert Rev Clin Immunol. 2024 Aug;20(8):895-911. doi: 10.1080/1744666X.2024.2326626. Epub 2024 Mar 27.
6
Hypoxia-associated autophagy flux dysregulation in human cancers.人类癌症中与缺氧相关的自噬通量失调
Cancer Lett. 2024 May 28;590:216823. doi: 10.1016/j.canlet.2024.216823. Epub 2024 Mar 21.
7
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers.BRAF 突变型黑色素瘤患者免疫疗法与靶向疗法疗效的比较以及将 cGAS 表达和非整倍体用作潜在预后生物标志物
Cancers (Basel). 2024 Mar 1;16(5):1027. doi: 10.3390/cancers16051027.
8
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.黑色素瘤中的免疫逃逸和转移机制:打破二分法。
Front Immunol. 2024 Feb 14;15:1336023. doi: 10.3389/fimmu.2024.1336023. eCollection 2024.
9
Immune checkpoint inhibitors in metastatic melanoma therapy (Review).免疫检查点抑制剂在转移性黑色素瘤治疗中的应用(综述)
Med Int (Lond). 2024 Feb 9;4(2):13. doi: 10.3892/mi.2024.137. eCollection 2024 Mar-Apr.
10
Mechanisms of Altered Immune Response in Skin Melanoma.皮肤黑色素瘤免疫反应改变的机制
Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30.